Journal of Medicinal Chemistry · 2021 · 37 citations · 24 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryMolecular PharmacologyEnzyme InhibitionAnticancer ActivityParp InhibitionPoly Adp-ribose Polymerase InhibitorsPoly(adp-ribose) Polymerase 1Poly(adp-ribose) Polymerase InhibitionPoly(adp-ribose) Polymerase Inhibitors
may serve as a lead compound for chemosensitizers and the (BRCA-1)-deficient cancer therapy.
24
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer, Nuala McCabe, Christopher J. Lord et al. · Nature · 2005 · 6.7K citations
DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139
Emmy P. Rogakou, Duane R. Pilch, Ann H. Orr et al. · Journal of Biological Chemistry · 1998 · 5.4K citations · Full text
Oscar Navarro, Roy A. Kelly, Steven P. Nolan · Journal of the American Chemical Society · 2003 · 530 citations
Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation
Bryan A. Gibson, Yajie Zhang, Hong Jiang et al. · Science · 2016 · 373 citations · Full text